Clinical trial
Trial for the Treatment of Alcohol Dependence
NCT00120601 · University of Sydney, Other · Unknown status
Key facts
| NCT number | NCT00120601 |
|---|---|
| Title | Trial for the Treatment of Alcohol Dependence |
| Official title | The Role of Pharmacotherapy in Prevention of Relapse in Alcohol Dependence |
| Lead sponsor | University of Sydney, Other |
| Collaborators | National Health and Medical Research Council, Australia Sydney South West Area Health Service South Eastern Area Health Service Wentworth Area Health Services |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism |
| Intervention type | Drug |
| Interventions | Naltrexone, Acamprosate |
| Enrollment | 200 |
| Start date | Mar 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Jul 18, 2005 |
| Last update posted | Jul 18, 2005 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: